1376P - Supportive care organization compared between patients and oncologist national survey

Date 28 September 2014
Event ESMO 2014
Session Poster Display session
Topics Supportive Measures
Bioethics, Legal, and Economic Issues
Presenter Florian Scotte
Citation Annals of Oncology (2014) 25 (suppl_4): iv481-iv485. 10.1093/annonc/mdu352
Authors F. Scotte1, C. Herve2, J. Tourani3, R. Bugat4, M. Rouge-Bugat4, F. Farsi5, N. Jovenin6, M. Namer7, C. Tournigand8, P. Leroy9, S. Oudard10, I. Krakowski11
  • 1Medical Oncology And Supportive Cancer Care Unit, Hospital G.Pompidou and Rene Descartes University, 75015 - Paris/FR
  • 2Ethics Department, Rene Descartes University, 75006 - Paris/FR
  • 3Pole Regional De Cancerologie, C.H.U. PoitiersJean Bernard Hospital, FR-86021 - Poitiers CEDEX/FR
  • 4Medical Oncology Department, Claudius Regaud Institute, Toulouse/FR
  • 5Réseau, Reseau Espace Sante Cancer Rhone Alpes, Lyon/FR
  • 6Medical Oncology, Institut Jean Godinot, 51056 - Reims/FR
  • 7Oncology, Clinique Saint George, Nice/FR
  • 8Medical Oncology, Hôpital Henri Mondor, APHP, Creteil/FR
  • 9Supportive Cancer Care Unit, hospital G.Pompidou, 75015 - paris/FR
  • 10Medical Oncology Service, Georges Pompidou Hospital and Rene Descartes University, 75015 - Paris/FR
  • 11Service D'oncologie Médicale, Centre Alexis Vautrin, Vandoeuvre-les-Nancy/FR



The Medical Doctor's (MD) perspective of supportive care in cancer (SCC) in France was previously assessed on a national survey. However, the opinion of patients (P) has never been evaluated nor compared to MD's perception. We promoted and compared P and MD awareness via national surveys to monitor implementation and information delivered to patients on SCC.


The French Speaking Association for SCC (AFSOS) conducted two observational studies, analyzed with a Chi2 test: - S1: a 30 points questionnaire sent to 2,263 physicians caring for cancer P (oncologists, radiotherapists, haematologists, gastroenterologists). - S2: a 40 points questionnaire performed by physicians to P, using a face-to-face method.


711 MDs returned S1 and S2 was conducted with 1,562 P. In S1, MDs declared relying on SCC organization (81%) but 19% of P declared they were offered to benefit from an organization called SCC (54% at diagnosis, 35% after complication). The name SCC was known by 34% of P, most frequently described as complementary care to specific treatments (55%). Palliative Care word had been previously heard by 80% P, mostly considered as care to improve quality of life during cancer treatment for 59%. In S2, professional resources identified outside the hospital were: General Practitioners (84%), Nurses (58%), Pharmacists (52%). According to P, the top 3 supportive care consultations proposed were psychology (61%), nutrition (55%) and announcement organization (55%), while MDs mentioned palliative care (98%), psychological care (98%), social care (98%). S2 showed that supportive treatment was prescribed to 63% of P, mostly by their oncologist (74%), and 64% of those P received information on side-effects. Epoetin was prescribed to 25% and analgesics to 73%, with discussion on adverse events respectively for 38% and 53%. MDs declared delivering information on adverse events to 49% of P receiving epoetin and to 74% of P running for analgesic treatment.


Oncologist is the cornerstone of SCC organization. Information as well as treatment must be developed to further enhance SCC and patient quality of care.


All authors have declared no conflicts of interest.